Clinical impact of extrahepatic metastatic patterns in patients with unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab
European Journal of Cancer · 2026-05 · 239 · 116704
DOI: 10.1016/j.ejca.2026.116704 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Journal of Cancer, 2026-05. Verfasst von Erwan Vo-Quang und 20 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology and Digestive Oncology Department, Georges Pompidou European Hospital, AP-HP, Paris, France; Department of Hepatology, Assistance Pu…. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular, Antibodies, Monoclonal, Humanized, Bevacizumab. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gastroenterology and Digestive Oncology Department, Georges Pompidou European Hospital, AP-HP, Paris, France; Department of Hepatology, Assistance Publique-Hôpitaux de Paris, Henri Mondor-Albert Chenevier University Hos…
- Centre de Recherche des Cordeliers, Sorbonne Université, Inserm, Université de Paris, team « Functional Genomics of Solid Tumors », Paris F- 75006, France; Department of Experimental and Clinical Medicine, Internal Medi…
- Hepatogastroenterology Department, La Pitié Salpêtrière Hospital, AP-HP, Sorbonne Université, Paris, France; INSERM UMR 1138, Centre de recherche des Cordeliers, Paris 75006, France.
- AP-HP, Liver Cancer and Innovative Therapy Unit, Hôpital Beaujon, 100 Boulevard du Général Leclerc, Clichy 92110, France; Centre de Recherche Sur l'Inflammation (CRI), INSERM, U1149, CNRS, ERL 8252, Paris F-75018, Franc…
- Department of Hepatology, Assistance Publique-Hôpitaux de Paris, Henri Mondor-Albert Chenevier University Hospital, Créteil, France.
- Department of Experimental and Clinical Medicine, Internal Medicine and Hepatology Unit, University of Firenze, Florence, Italy.
Zitieren
APA
Vo-Quang, E., Campani, C., Allaire, M., Bouattour, M., Regnault, H., Marra, F., Sutter, O., Leroy, V., Trepo, E., Mouri, S., Thabut, D., Ozenne, V., Sidali, S., Hollande, C., Boros, C., Nahon, P., Ganne-Carrié, N., Lequoy, M., Amaddeo, G., …, & Paris Liver Cancer Group (2026). Clinical impact of extrahepatic metastatic patterns in patients with unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab. European Journal of Cancer, 239, 116704. https://doi.org/10.1016/j.ejca.2026.116704
Vancouver
Vo-Quang E, Campani C, Allaire M, Bouattour M, Regnault H, Marra F, et al. Clinical impact of extrahepatic metastatic patterns in patients with unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab. European Journal of Cancer. 2026;239:116704. doi:10.1016/j.ejca.2026.116704
BibTeX
@article{VoQuang2026,
author = {Vo-Quang, Erwan and Campani, Claudia and Allaire, Manon and Bouattour, Mohamed and Regnault, Hélène and Marra, Fabio and Sutter, Olivier and Leroy, Vincent and Trepo, Eric and Mouri, Sarah and Thabut, Dominique and Ozenne, Violaine and Sidali, Sabrina and Hollande, Clémence and Boros, Carina and Nahon, Pierre and Ganne-Carrié, Nathalie and Lequoy, Marie and Amaddeo, Giuliana and Nault, Jean Charles and Paris Liver Cancer Group, Paris Liver Cancer Group},
title = {Clinical impact of extrahepatic metastatic patterns in patients with unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab},
journal = {European Journal of Cancer},
year = {2026},
volume = {239},
pages = {116704},
doi = {10.1016/j.ejca.2026.116704}
}
EUVIMED